Dianthus Therapeutics, Inc.

Contributing Author

Recent Articles by Dianthus Therapeutics, Inc.

May-29	Dianthus Therapeutics to Webcast Presentation at the Jefferies Global Healthcare Conference DNTH GlobeNewswire
May-22	Dianthus Therapeutics Appoints Simon Read, Ph.D., to Board of Directors DNTH GlobeNewswire
May-12	Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial Results DNTH GlobeNewswire
May-05	Dianthus Therapeutics Completes Enrollment of Phase 2 MaGic Trial of DNTH103 in Generalized Myasthenia Gravis With Top-Line Results Expected in September DNTH GlobeNewswire